相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The impact of indigenous microbes on Parkinson's disease
Timothy Sampson
NEUROBIOLOGY OF DISEASE (2020)
Metabolomics-based identification of metabolic alterations in PARK2
Ayami Okuzumi et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2019)
Different Circulating Trace Amine Profiles in De Novo and Treated Parkinson's Disease Patients
Giovanni D'Andrea et al.
SCIENTIFIC REPORTS (2019)
Transneuronal Propagation of Pathologic α-Synuclein from the Gut to the Brain Models Parkinson's Disease
Sangjune Kim et al.
NEURON (2019)
Discovery and inhibition of an interspecies gut bacterial pathway for Levodopa metabolism
Vayu Maini Rekdal et al.
SCIENCE (2019)
Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression
Velma T. E. Aho et al.
EBIOMEDICINE (2019)
Unraveling gut microbiota in Parkinson's disease and atypical parkinsonism
Michela Barichella et al.
MOVEMENT DISORDERS (2019)
Gut bacterial tyrosine decarboxylases restrict levels of levodopa in the treatment of Parkinson's disease
Sebastiaan P. van Kessel et al.
NATURE COMMUNICATIONS (2019)
Dysbiosis of gut microbiota and microbial metabolites in Parkinson's Disease
Meng-Fei Sun et al.
AGEING RESEARCH REVIEWS (2018)
Alteration of the fecal microbiota in Chinese patients with Parkinson's disease
Yiwei Qian et al.
BRAIN BEHAVIOR AND IMMUNITY (2018)
Regulation of the Immune Response by the Aryl Hydrocarbon Receptor
Cristina Gutierrez-Vazquez et al.
IMMUNITY (2018)
Potential biomarkers of Parkinson's disease revealed by plasma metabolic profiling
Huiyuan Zhao et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2018)
Parkinson's disease patients have a complex phenotypic and functional Th1 bias: cross-sectional studies of CD4+Th1/Th2/T17 and Treg in drug-naive and drugtreated patients
Natasa Kustrimovic et al.
JOURNAL OF NEUROINFLAMMATION (2018)
Stool Immune Profiles Evince Gastrointestinal Inflammation in Parkinson's Disease
Madelyn C. Houser et al.
MOVEMENT DISORDERS (2018)
Inadequate Production of H2 by Gut Microbiota and Parkinson Disease
Sergej M. Ostojic
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2018)
Gut Microbiota-Derived Tryptophan Metabolites Modulate Inflammatory Response in Hepatocytes and Macrophages
Smitha Krishnan et al.
CELL REPORTS (2018)
Gut microbiota in patients with Parkinson's disease in southern China
Aiqun Lin et al.
PARKINSONISM & RELATED DISORDERS (2018)
Global, regional, and national burden of Parkinson's disease, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016
E. Ray Dorsey et al.
LANCET NEUROLOGY (2018)
Quantification of hydrogen production by intestinal bacteria that are specifically dysregulated in Parkinson's disease
Anzu Suzuki et al.
PLOS ONE (2018)
Metabolomic investigations in cerebrospinal fluid of Parkinson's disease
Desiree Willkommen et al.
PLOS ONE (2018)
The vermiform appendix impacts the risk of developing Parkinson's disease
Bryan A. Killinger et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Changes in kynurenine pathway metabolism in Parkinson patients with L-DOPA-induced dyskinesia
Jesper F. Havelund et al.
JOURNAL OF NEUROCHEMISTRY (2017)
Dopaminergic Regulation of Innate Immunity: a Review
Monica Pinoli et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2017)
Global, regional, and national burden of neurological disorders during 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015
Valery L. Feigin et al.
LANCET NEUROLOGY (2017)
Distinct Metabolomic Signature in Cerebrospinal Fluid in Early Parkinson's Disease
Jean-Pierre Trezzi et al.
MOVEMENT DISORDERS (2017)
Metabolic Profiling of Parkinson's Disease and Mild Cognitive Impairment
Florence Burte et al.
MOVEMENT DISORDERS (2017)
Profiling Novel Metabolic Biomarkers for Parkinson's Disease Using In-depth Metabolomic Analysis
Wei Han et al.
MOVEMENT DISORDERS (2017)
Parkinson's Disease and Parkinson's Disease Medications Have Distinct Signatures of the Gut Microbiome
Erin M. Hill-Burns et al.
MOVEMENT DISORDERS (2017)
Metabolomic biomarkers as strong correlates of Parkinson disease progression
Peter A. LeWitt et al.
NEUROLOGY (2017)
Structural changes of gut microbiota in Parkinson's disease and its correlation with clinical features
Wei Li et al.
SCIENCE CHINA-LIFE SCIENCES (2017)
Carbidopa, a drug in use for management of Parkinson disease inhibits T cell activation and autoimmunity
Huabin Zhu et al.
PLOS ONE (2017)
Carbidopa is an activator of aryl hydrocarbon receptor with potential for cancer therapy
Jiro Ogura et al.
BIOCHEMICAL JOURNAL (2017)
Gut microbiota in Parkinson disease in a northern German cohort
Franziska Hopfner et al.
BRAIN RESEARCH (2017)
Analysis of Gut Microbiota in Patients with Parkinson's Disease
V. A. Petrov et al.
BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE (2017)
The gut-brain axis: is intestinal inflammation a silent driver of Parkinson's disease pathogenesis?
Madelyn C. Houser et al.
NPJ PARKINSONS DISEASE (2017)
Identification of novel biomarkers for Parkinson's disease by metabolomic technologies
Taku Hatano et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2016)
Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson's Disease
Timothy R. Sampson et al.
CELL (2016)
Anti-neuroinflammatory activities of indole alkaloids from kanjang (Korean fermented soy source) in lipopolysaccharide-induced BV2 microglial cells
Dong-Cheol Kim et al.
FOOD CHEMISTRY (2016)
Multi-platform mass spectrometry analysis of the CSF and plasma metabolomes of rigorously matched amyotrophic lateral sclerosis, Parkinson's disease and control subjects
Anna Wuolikainen et al.
MOLECULAR BIOSYSTEMS (2016)
Highly specific changes in antioxidant levels and lipid peroxidation in Parkinson's disease and its progression: Disease and staging biomarkers and new drug targets
Carine Coneglian de Farias et al.
NEUROSCIENCE LETTERS (2016)
Short chain fatty acids and gut microbiota differ between patients with Parkinson's disease and age-matched controls
Marcus M. Unger et al.
PARKINSONISM & RELATED DISORDERS (2016)
p-Cresyl sulfate suppresses lipopolysaccharide-induced anti-bacterial immune responses in murine macrophages in vitro
Takahiro Shiba et al.
TOXICOLOGY LETTERS (2016)
Dopaminergic Receptors on CD4+T Naive and Memory Lymphocytes Correlate with Motor Impairment in Patients with Parkinson's Disease
Natasa Kustrimovic et al.
SCIENTIFIC REPORTS (2016)
Provotella-derived hydrogen sulfide, constipation, and neuroprotection in Parkinson's disease
Yusuf Ozgur Cakmak
MOVEMENT DISORDERS (2015)
Colonic Bacterial Composition in Parkinson's Disease
Ali Keshavarzian et al.
MOVEMENT DISORDERS (2015)
NMR metabonomics of cerebrospinal fluid distinguishes between Parkinson's disease and controls
Anders Ohman et al.
NEUROSCIENCE LETTERS (2015)
The bilateral responsiveness between intestinal microbes and IgA
Andrew J. Macpherson et al.
TRENDS IN IMMUNOLOGY (2015)
Comprehensive urinary metabolomic profiling and identification of potential noninvasive marker for idiopathic Parkinson's disease
Hemi Luan et al.
SCIENTIFIC REPORTS (2015)
Tyramine biosynthesis is transcriptionally induced at low pH and improves the fitness of Enterococcus faecalis in acidic environments
Marta Perez et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2015)
LC MS-Based Urinary Metabolite Signatures in Idiopathic Parkinson's Disease
Hemi Luan et al.
JOURNAL OF PROTEOME RESEARCH (2015)
Gut Microbiota Are Related to Parkinson's Disease and Clinical Phenotype
Filip Scheperjans et al.
MOVEMENT DISORDERS (2015)
Intestinal Dysbiosis and Lowered Serum Lipopolysaccharide-Binding Protein in Parkinson's Disease
Satoru Hasegawa et al.
PLOS ONE (2015)
Mechanisms of Molecular Mimicry Involving the Microbiota in Neurodegeneration
Robert P. Friedland
JOURNAL OF ALZHEIMERS DISEASE (2015)
Discovery and Characterization of Gut Microbiota Decarboxylases that Can Produce the Neurotransmitter Tryptamine
Brianna B. Williams et al.
CELL HOST & MICROBE (2014)
Gut microbiome composition and function in experimental colitis during active disease and treatment-induced remission
Michelle G. Rooks et al.
ISME JOURNAL (2014)
Effects of intestinal bacteria-derived p-cresyl sulfate on Th1-type immune response in vivo and in vitro
Takahiro Shiba et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2014)
Prediction and quantification of bioactive microbiota metabolites in the mouse gut
Gautham V. Sridharan et al.
NATURE COMMUNICATIONS (2014)
Metabolite and Peptide Levels in Plasma and CSF Differentiating Healthy Controls from Patients with Newly Diagnosed Parkinson's Disease
Miles Trupp et al.
JOURNAL OF PARKINSONS DISEASE (2014)
Microbial regulation of host hydrogen sulfide bioavailability and metabolism
Xinggui Shen et al.
FREE RADICAL BIOLOGY AND MEDICINE (2013)
Dopamine Receptor D3 Expressed on CD4+ T Cells Favors Neurodegeneration of Dopaminergic Neurons during Parkinson's Disease
Hugo Gonzalez et al.
JOURNAL OF IMMUNOLOGY (2013)
3-Hydroxykynurenine and Other Parkinson's Disease Biomarkers Discovered by Metabolomic Analysis
Peter A. LeWitt et al.
MOVEMENT DISORDERS (2013)
Serum Metabolomics of Slow vs. Rapid Motor Progression Parkinson's Disease: a Pilot Study
James R. Roede et al.
PLOS ONE (2013)
Tyramine and Phenylethylamine Biosynthesis by Food Bacteria
Angela Marcobal et al.
CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION (2012)
Is alpha-synuclein in the colon a biomarker for premotor Parkinson's Disease? Evidence from 3 cases
Kathleen M. Shannon et al.
MOVEMENT DISORDERS (2012)
Hydrogen Sulfide and Cell Signaling
Ling Li et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 51, 2011 (2011)
Inhaled Hydrogen Sulfide Prevents Neurodegeneration and Movement Disorder in a Mouse Model of Parkinson's Disease
Kotaro Kida et al.
ANTIOXIDANTS & REDOX SIGNALING (2011)
Neuroprotective effects of hydrogen sulfide on Parkinson's disease rat models
Li-Fang Hu et al.
AGING CELL (2010)
The immunoregulatory role of dopamine: An update
Chandrani Sarkar et al.
BRAIN BEHAVIOR AND IMMUNITY (2010)
p-Cresol inhibits IL-12 production by murine macrophages stimulated with bacterial immunostimulant
Koji Kawakami et al.
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY (2009)
Molecular hydrogen is protective against 6-hydroxydopamine-induced nigrostriatal degeneration in a rat model of Parkinson's disease
Yuan Fu et al.
NEUROSCIENCE LETTERS (2009)
Hydrogen in Drinking Water Reduces Dopaminergic Neuronal Loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine Mouse Model of Parkinson's Disease
Kyota Fujita et al.
PLOS ONE (2009)
Metabolomic Profiling in LRRK2-Related Parkinson's Disease
Krisztina K. Johansen et al.
PLOS ONE (2009)
Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites
William R. Wikoff et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Metabolic profiling of Parkinson's disease: evidence of biomarker from gene expression analysis and rapid neural network detection
Shiek S. S. J. Ahmed et al.
JOURNAL OF BIOMEDICAL SCIENCE (2009)
Rapid detection and quantification of tyrosine decarboxylase gene (tdc) and its expression in gram-positive bacteria associated with fermented foods using PCR-based methods
Sandra Torriani et al.
JOURNAL OF FOOD PROTECTION (2008)
Progression of motor impairment and disability in Parkinson disease - A population-based study
G Alves et al.
NEUROLOGY (2005)
Increased dopamine content in lymphocytes from high-dose L-Dopa-treated Parkinson's disease patients
C Rajda et al.
NEUROIMMUNOMODULATION (2005)
Dopamine, through the extracellular signal-regulated kinase pathway, downregulates CD4+CD25+ regulatory T-cell activity:: Implications for neurodegeneration
J Kipnis et al.
JOURNAL OF NEUROSCIENCE (2004)
Production of cellulose and curli fimbriae by members of the family Enterobacteriaceae isolated from the human gastrointestinal tract
X Zogaj et al.
INFECTION AND IMMUNITY (2003)
Idiopathic Parkinson's disease:: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen
H Braak et al.
JOURNAL OF NEURAL TRANSMISSION (2003)
Staging of brain pathology related to sporadic Parkinson's disease
H Braak et al.
NEUROBIOLOGY OF AGING (2003)
Pseudomonas pickettii:: A common soil and aerobic groundwater bacteria with pathogenic and biodegradation properties
MR Bruins et al.
ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY (2000)
分享论文
